Respiratory Tract Drugs: Bronchodilators
TSPIR2 “Spiriva Respimat” 2.5mcg/ puff (5mcg/dose), 30 dose/bot
適應症：慢性阻塞性肺疾（包括慢性支氣管炎及肺氣腫）維持治療。
Usual dose:
One capsule (18 mcg) qd, via HandiHaler inhalation device.
1-2 puff qd.
Precaution:
Bladder-neck obstruction, glaucoma, narrow angle, prostate hypertrophy, moderate to severe renal failure.
Adverse effect:
Common: constipation, pharyngitis, sinusitis, upper respiratory infection, xerostomia.
Serious: bowel obstruction, cerebrovascular accident.
Related Entries
(Visited 38 times, 1 visits today)